Remove Healthcare Remove IT Remove Manufacturing Remove Paper
article thumbnail

How a global research and manufacturing company achieves regulatory compliance

OpenText Information Management

As a Contract Research and Manufacturing organization with over 330 clients around the globe, regulatory compliance is non-negotiable for Syngene International. Its integrated scientific solutions necessitate careful documenting of trials, test results, product formulae, manufacturing processes, and more.

article thumbnail

The hidden threats facing your intellectual property

IT Governance

For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured. Sinovel was convicted of stealing trade secrets and ordered to pay a $1.5 million fine. Preventive measures.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mastering healthcare data governance with data lineage

IBM Big Data Hub

The healthcare industry faces arguably the highest stakes when it comes to data governance. For starters, healthcare organizations constantly encounter vast (and ever-increasing) amounts of highly regulated personal data. The impact of healthcare data usage on people’s lives lies at the heart of why data governance in healthcare is so crucial.In

article thumbnail

The most valuable AI use cases for business

IBM Big Data Hub

McDonald’s is building AI solutions for customer care with IBM Watson AI technology and NLP to accelerate the development of its automated order taking (AOT) technology. Not only will this help scale the AOT tech across markets, but it will also help tackle integrations including additional languages, dialects and menu variations.

article thumbnail

Regulatory Update: NAIC Summer 2018 National Meeting

Data Matters

The Task Force stressed that the guidance provided in the white paper will not be designed to preempt state authority but rather will assist regulators in providing greater consistency among states’ review of predictive models. The Task Force aims to complete the white paper by the fall of 2018.